Diabetes Discovery Leaves Doctors Speechless

A treatment was discovered by the scientists which could reverse the type 2 diabetes.

The researchers found a protein. This protein is already naturally produced in the body and is the cure for the disease in mice, and the researchers are confident that it could also be replicated in humans.

This breakthrough raises the hope of a cheap drug which could halt one of the fastest growing diseases of the world.

This protein which is called FGF1 plays a natural role in human cell growth and tissue repair, but it never enters the bloodstream. People who are diabetes experts found out that if they inject protein into a muscle and interacted with the blood, it can dramatically reduce blood sugar levels.

This protein also reverses the root cause of type 2 diabetes by making the metabolic system react to insulin when it had been failing to do that. Just one injection of this protein restored the blood sugar levels to a healthy range in obese mice with a rodent version of type 2 diabetes. Researchers found out that the continued treatment with the protein reversed the insensitivity of the insulin.

People with this disease become less sensitive when it comes to the effects of the hormone by forcing up their blood sugar.

Professor Ronald Evans, of the Salk Institute in La Jolla, California said that this is a big deal because the treatment is simple to make. He also added that they are at a very early stage, but they already know so much about the protein which is why they have a head start.

This disease represents an epidemic in the modern world and its current treatments are not sufficient. But this treatment offers a new method for the control of glucose in a powerful, potent and unexpected way. It was surprising the way the protein was reintroduced to the body.

The available diabetes treatments who exist current have one aim and that is to boost the insulin levels and to reverse the insulin resistance by altering the gene activity. But these drugs are causing unwanted side effects which may lower blood glucose levels too far and this may lead to a life-threatening hypoglycaemia.

The scientists found out that the mice who didn’t have this protein quickly developed diabetes when they were placed on a high-fat diet. This was enough to suggest that the protein plays a key role when it comes to managing blood glucose levels.

When the scientists injected FGF1 into obese mice with diabetes in order to assess the protein’s effect on metabolism, they found out that a single dose can rapidly cause the blood sugar to drop to normal levels.

Dr. Michael Downes, also from the Salk Institute said that many previous studies which injected FGF1 showed no effect on healthy mice. But when they injected it into a diabetic mouse, they saw the dramatic improvement in glucose.

This protein has many advantages over the existing diabetes drugs which are associated with the side effects. These side effects range from unwanted weight gain to dangerous heart and liver problems.

The only thing which the scientists do not fully understand is how the protein works, but they have hope that others will begin researching the properties of the protein.

It was said by Professor Evans that there are a lot of questions which emerge from this work and the avenues for investigating FGF1 in diabetes and metabolism are wide open. He also thinks that when others will see these findings they will jump in and help them with their own research.

Type 2 diabetes is a disease that can be developed in adulthood and is linked to lifestyle. It can reduce life expectancy and it can lead to complications such as amputation that can seriously affect the quality of life and blindness.

The core problem of this disease is the inability of the body to respond to insulin in the way it should. This disease is different from type 1 diabetes which is an autoimmune disorder that is normally present from childhood and it can occur when the body cannot produce its own insulin.

Be the first to comment

Leave a Reply

Your email address will not be published.


*